BTSG vs the Top Picks average
| Pillar | BTSG | Book avg | Diff |
|---|---|---|---|
| Quality | 0.51 | 0.84 | -0.33 |
| Growth | 0.92 | 0.84 | +0.08 |
| Value | 0.34 | 0.78 | -0.44 |
Averaged across the 30 names in today's Top Picks (mean score 81.5). A name can beat these averages and still be absent from the book — it also applies concentration limits.
One point per daily model run. The range autoscales, so a flat-looking line can still hide 1–2 point moves — read the From → To values for the actual range.
Analyst estimate revisions
| 30-day change | +6.7% |
|---|---|
| 90-day change | +7.8% |
| Forward EPS estimate | $2.28 |
Over the last 90 days, what analysts expect BTSG to earn is materially higher (+7.8%). The estimate is derived from price and forward P/E captured at the same instant, so a moving share price does not move this number — only a changed forecast does.
A rising estimate means expectations are improving, not that the price has failed to keep up — and estimates get cut as readily as they get raised. It is not part of the Bull Rankings score. Biggest movers across the market →
Math only — share count is floor(portfolio × risk% ÷ (price × stop%)). Doesn't account for commissions, slippage, gap risk, or position-correlation across your book. Inputs persist locally; never sent to the server. Not investment advice.
BrightSpring Health Services, Inc. (BTSG): score, valuation & FAQ
BrightSpring Health Services, Inc. (BTSG) is a Health Information Services company that scores 54.3 out of 100 on the Bull Rankings quality-growth model — a middling reading. The score blends three pillars — quality (durable returns, healthy margins, low leverage), growth (revenue and earnings), and value (valuation versus sector peers) — into one number, refreshed daily; it is a screen, not a buy recommendation.
Its strongest graded signals are Rev (A-). On valuation, BTSG sits about 112% above our discounted-cash-flow fair value — the current price implies roughly 37% annual free-cash-flow growth over the next decade.
Is BTSG a good stock to buy?
Bull Rankings scores BTSG 54.3 out of 100 on its quality-growth model, which is a middling reading. That is driven by Rev (A-). A score is a quantitative screen of BrightSpring Health Services, Inc.'s fundamentals, not personalised financial advice — weigh it against your own time horizon and risk tolerance, and read the risk factors below before acting.
Why does BTSG score 54.3 on Bull Rankings?
The quality-growth score blends three pillars — quality (returns on capital, margins, leverage, earnings quality), growth (revenue and earnings expansion), and value (valuation versus sector peers). BTSG earns its highest marks on Rev (A-). Each pillar is graded against sector-aware thresholds, then combined into the single 0–100 score.
Is BTSG overvalued or undervalued?
Based on $58.87, BTSG sits about 112% above our discounted-cash-flow fair value — the current price implies roughly 37% annual free-cash-flow growth over the next decade. It trades at a 52.6x P/E (graded C). Discounted-cash-flow estimates are sensitive to growth and discount-rate assumptions, so treat this as a cross-check, not a price target.
What are the main risks of investing in BTSG?
Trailing P/E 52.6x prices in sustained high growth — any quarter that disappoints triggers sharp re-rating. Beta 1.88 implies above-market volatility — position-size to the drawdowns this name will produce in a market correction, not to its bull-case return. Net margin 2.5% is thin — operating leverage cuts both ways; input-cost inflation or pricing pressure hits the bottom line first.
New to these metrics? The guides explain free cash flow, how the score works, and more in the learn hub — or run another name through the screener.
Bull Rankings is an automated fundamentals screen for research and education. It is not investment advice, and nothing here is a recommendation to buy or sell any security. Do your own research and consider consulting a licensed financial advisor.